BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12109912)

  • 1. Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure.
    Bolognesi ML; Bixel MG; Marucci G; Bartolini M; Krauss M; Angeli P; Antonello A; Rosini M; Tumiatti V; Hucho F; Melchiorre C
    J Med Chem; 2002 Jul; 45(15):3286-95. PubMed ID: 12109912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 2. Role of polymethylene chain lengths separating amine functions and of substituents on the terminal nitrogen atoms.
    Rosini M; Bixel MG; Marucci G; Budriesi R; Krauss M; Bolognesi ML; Minarini A; Tumiatti V; Hucho F; Melchiorre C
    J Med Chem; 2002 Apr; 45(9):1860-78. PubMed ID: 11960498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists.
    Rosini M; Budriesi R; Bixel MG; Bolognesi ML; Chiarini A; Hucho F; Krogsgaard-Larsen P; Mellor IR; Minarini A; Tumiatti V; Usherwood PN; Melchiorre C
    J Med Chem; 1999 Dec; 42(25):5212-23. PubMed ID: 10602706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties.
    Tumiatti V; Minarini A; Milelli A; Rosini M; Buccioni M; Marucci G; Ghelardini C; Bellucci C; Melchiorre C
    Bioorg Med Chem; 2007 Mar; 15(6):2312-21. PubMed ID: 17276075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines.
    Minarini A; Bolognesi ML; Budriesi R; Canossa M; Chiarini A; Spampinato S; Melchiorre C
    J Med Chem; 1994 Sep; 37(20):3363-72. PubMed ID: 7932564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships among methoctramine-related polymethylene tetraamines. 3. Effect of the four nitrogens on M2 muscarinic blocking activity as revealed by symmetrical and unsymmetrical polyamines.
    Quaglia W; GiardinĂ  D; Marucci G; Melchiorre C; Minarini A; Tumiatti V
    Farmaco; 1991 Mar; 46(3):417-34. PubMed ID: 1892500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
    J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors.
    Melchiorre C; Cassinelli A; Quaglia W
    J Med Chem; 1987 Jan; 30(1):201-4. PubMed ID: 3806594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymethylene tetraamine backbone as template for the development of biologically active polyamines.
    Melchiorre C; Antonello A; Banzi R; Bolognesi ML; Minarini A; Rosini M; Tumiatti V
    Med Res Rev; 2003 Mar; 23(2):200-33. PubMed ID: 12500289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methoctramine-related polymethylene tetraamines. 4. Chirality effect on M2 muscarinic receptor blocking activity.
    GiardinĂ  D; Marrazzo A; Marucci G; Piloni MG; Quaglia W
    Farmaco; 1991; 46(7-8):861-72. PubMed ID: 1793471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.
    Tumiatti V; Rosini M; Bartolini M; Cavalli A; Marucci G; Andrisano V; Angeli P; Banzi R; Minarini A; Recanatini M; Melchiorre C
    J Med Chem; 2003 Mar; 46(6):954-66. PubMed ID: 12620072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activators.
    Melchiorre C; Bolognesi ML; Budriesi R; Ghelardini C; Chiarini A; Minarini A; Rosini M; Tumiatti V; Wade EJ
    J Med Chem; 2001 Nov; 44(24):4035-8. PubMed ID: 11708906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists.
    Melchiorre C; Minarini A; Budriesi R; Chiarini A; Spampinato S; Tumiatti V
    Life Sci; 1995; 56(11-12):837-44. PubMed ID: 10188783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further investigation on methoctramine-related tetraamines: effects of terminal N-substitution and of chain length separating the four nitrogens on M2 muscarinic receptor blocking activity.
    Minarini A; Budriesi R; Chiarini A; Melchiorre C; Tumiatti V
    Farmaco; 1991 Oct; 46(10):1167-78. PubMed ID: 1815579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of tripitramine, a polymethylene tetraamine displaying high selectivity and affinity for muscarinic M2 receptors.
    Chiarini A; Budriesi R; Bolognesi ML; Minarini A; Melchiorre C
    Br J Pharmacol; 1995 Apr; 114(7):1507-17. PubMed ID: 7606355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships among methoctramine-related polymethylene tetraamines. Chain-length and substituent effects on M-2 muscarinic receptor blocking activity.
    Melchiorre C; Quaglia W; Picchio MT; GiardinĂ  D; Brasili L; Angeli P
    J Med Chem; 1989 Jan; 32(1):79-84. PubMed ID: 2909747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of methoctramine, a muscarinic M2 receptor antagonist, on muscarinic and nicotinic cholinoceptors in guinea-pig airways in vivo and in vitro.
    Watson N; Barnes PJ; Maclagan J
    Br J Pharmacol; 1992 Jan; 105(1):107-12. PubMed ID: 1596672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties.
    Tumiatti V; Andrisano V; Banzi R; Bartolini M; Minarini A; Rosini M; Melchiorre C
    J Med Chem; 2004 Dec; 47(26):6490-8. PubMed ID: 15588084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the stimulant activities of oxotremorine analogues on the frog rectus abdominis and the guinea pig ileum.
    Ringdahl B
    Eur J Pharmacol; 1984 Mar; 99(2-3):177-84. PubMed ID: 6234180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro.
    Eglen RM; Harris GC
    Br J Pharmacol; 1993 Aug; 109(4):946-52. PubMed ID: 8401947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.